207 related articles for article (PubMed ID: 29481809)
1. Newer therapeutic strategies for soft-tissue sarcomas.
Bourcier K; Italiano A
Pharmacol Ther; 2018 Aug; 188():118-123. PubMed ID: 29481809
[TBL] [Abstract][Full Text] [Related]
2. Olaratumab: PDGFR-α inhibition as a novel tool in the treatment of advanced soft tissue sarcomas.
Vincenzi B; Badalamenti G; Napolitano A; Spalato Ceruso M; Pantano F; Grignani G; Russo A; Santini D; Aglietta M; Tonini G
Crit Rev Oncol Hematol; 2017 Oct; 118():1-6. PubMed ID: 28917265
[TBL] [Abstract][Full Text] [Related]
3. Advances of systemic treatment for adult soft-tissue sarcoma.
Liu W; Jiang Q; Zhou Y
Chin Clin Oncol; 2018 Aug; 7(4):42. PubMed ID: 30173532
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma.
Hartmann JT; Patel S
Drugs; 2005; 65(2):167-78. PubMed ID: 15631540
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
Hartmann JT
Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
[TBL] [Abstract][Full Text] [Related]
6. The Current Landscape of Early Drug Development for Patients With Sarcoma.
Wilky BA; Jones RL; Keedy VL
Am Soc Clin Oncol Educ Book; 2017; 37():807-810. PubMed ID: 28561654
[TBL] [Abstract][Full Text] [Related]
7. Investigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma.
Martin-Liberal J; Pérez E; García Del Muro X
Expert Opin Investig Drugs; 2019 Jan; 28(1):39-50. PubMed ID: 30513001
[TBL] [Abstract][Full Text] [Related]
8. Novel treatment strategies for soft tissue sarcoma.
Kasper B; Gil T; D'Hondt V; Gebhart M; Awada A
Crit Rev Oncol Hematol; 2007 Apr; 62(1):9-15. PubMed ID: 17141519
[TBL] [Abstract][Full Text] [Related]
9. Role of new chemotherapy agents in soft tissue sarcoma.
von Mehren M
J Natl Compr Canc Netw; 2005 Mar; 3(2):198-205. PubMed ID: 19817029
[TBL] [Abstract][Full Text] [Related]
10. Next frontiers in systemic therapy for soft tissue sarcoma.
Yen CC; Chen TW
Chin Clin Oncol; 2018 Aug; 7(4):43. PubMed ID: 30173533
[TBL] [Abstract][Full Text] [Related]
11. RG7112, a small-molecule inhibitor of MDM2, enhances trabectedin response in soft tissue sarcomas.
Obrador-Hevia A; Martinez-Font E; Felipe-Abrio I; Calabuig-Fariñas S; Serra-Sitjar M; López-Guerrero JA; Ramos R; Alemany R; Martín-Broto J
Cancer Invest; 2015; 33(9):440-50. PubMed ID: 26288114
[TBL] [Abstract][Full Text] [Related]
12. Olaratumab: A Novel Platelet-Derived Growth Factor Receptor α-Inhibitor for Advanced Soft Tissue Sarcoma.
Andrick BJ; Gandhi A
Ann Pharmacother; 2017 Dec; 51(12):1090-1098. PubMed ID: 28778132
[TBL] [Abstract][Full Text] [Related]
13. Potential for immunotherapy in soft tissue sarcoma.
Tseng WW; Somaiah N; Engleman EG
Hum Vaccin Immunother; 2014; 10(11):3117-24. PubMed ID: 25625925
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies.
Linch M; Miah AB; Thway K; Judson IR; Benson C
Nat Rev Clin Oncol; 2014 Apr; 11(4):187-202. PubMed ID: 24642677
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
Nathenson MJ; Conley AP; Sausville E
Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
[TBL] [Abstract][Full Text] [Related]
16. Olaratumab for soft tissue sarcoma.
Teyssonneau D; Italiano A
Expert Opin Biol Ther; 2017 Aug; 17(8):1019-1025. PubMed ID: 28691538
[TBL] [Abstract][Full Text] [Related]
17. Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches.
Mocellin S; Rossi CR; Brandes A; Nitti D
Cancer Treat Rev; 2006 Feb; 32(1):9-27. PubMed ID: 16338075
[TBL] [Abstract][Full Text] [Related]
18. Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapy.
Davis EJ; Chugh R
Drug Des Devel Ther; 2017; 11():3579-3587. PubMed ID: 29263653
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new.
Frezza AM; Stacchiotti S; Gronchi A
BMC Med; 2017 Jun; 15(1):109. PubMed ID: 28571564
[TBL] [Abstract][Full Text] [Related]
20. Systematic therapy for unresectable or metastatic soft-tissue sarcomas: past, present, and future.
Morgan SS; Cranmer LD
Curr Oncol Rep; 2011 Aug; 13(4):331-49. PubMed ID: 21633784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
